Skip to content


BMC Cancer

BMC Cancer: In support of World Cancer Day

New Content ItemTo mark World Cancer Day, BMC Cancer would like to highlight some highly accessed and fascinating research on breast cancer and cancer survivorship. In recognition of the importance of such topics BMC Cancer is delighted to announce its new section on "supportive therapy, survivorship and psychosocial oncology".

Featured blog: Highlights of 2017!

New Content Item2017 was another fascinating year for BMC Cancer; we published many exciting papers covering a wide range of topics and launched our thematic series on CAR Immunotherapy. With the New Year, we look back on some of the most talked about articles of 2017.

Call for papers: The Advances of CAR Immunotherapy within Oncology Clinics

New Content ItemBMC Cancer and BMC Biotechnology are delighted to announce the launch of a new cross-journal thematic series focused on the emerging field of Chimeric Antigen Receptor (CAR) Immunotherapy, which will review and feature the role of synthetic biology and gene engineering in CAR Immunotherapy, but also the advances of CAR Immunotherapy within oncology clinics.

Featured video: Microparticles, breast cancer's secret weapon?

Read the article


View all articles
View all articles

Aims and scope

BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.


Consulting Editors

Stephen P. Povoski, Consulting Editor

Stephen P. Povoski, MD is Professor of Surgery and Surgical Oncologist at the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Comprehensive Cancer Center of The Ohio State University Wexner Medical Center in Columbus, Ohio. He joined the Editorial Board of BMC Cancer as a Section Editor in 2012, and was awarded the 2015 Section Editor of the Year Award from among the 290 BioMed Central journals. Since 2017, he has served as a Consulting Editor for BMC Cancer.



Latest Tweets


2016 Journal Metrics